ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 191 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $402 | -74.6% | 126,812 | -49.6% | 0.03% | -82.7% |
Q4 2022 | $1,581 | -99.5% | 251,384 | +689.4% | 0.20% | +326.1% |
Q3 2022 | $344,000 | -74.6% | 31,846 | -78.6% | 0.05% | -74.7% |
Q1 2022 | $1,356,000 | -20.8% | 148,804 | +29.6% | 0.18% | -15.3% |
Q4 2021 | $1,713,000 | +370.6% | 114,815 | +723.0% | 0.22% | +424.4% |
Q2 2021 | $364,000 | +27.7% | 13,951 | +23.8% | 0.04% | -12.8% |
Q4 2020 | $285,000 | +3.3% | 11,273 | +6.1% | 0.05% | +46.9% |
Q4 2019 | $276,000 | – | 10,622 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vida Ventures Advisors, LLC | 1,798,163 | $46,213,000 | 13.24% |
Wildcat Capital Management, LLC | 1,716,370 | $44,111,000 | 5.71% |
TPG Group Holdings (SBS) Advisors, Inc. | 18,716,306 | $481,009,000 | 4.77% |
Copernicus Capital Management, LLC | 15,000 | $386,000 | 4.67% |
Coastal Bridge Advisors, LLC | 301,240 | $7,742,000 | 1.79% |
Lombard Odier Asset Management (Switzerland) SA | 914,416 | $23,500,000 | 1.46% |
Casdin Capital, LLC | 2,100,000 | $53,970,000 | 1.34% |
Pier Capital, LLC | 450,182 | $11,570,000 | 1.20% |
Ghost Tree Capital, LLC | 150,000 | $3,855,000 | 1.13% |
Sessa Capital IM, L.P. | 750,000 | $19,275,000 | 0.95% |